Abstract
In the last years novel therapeutic approaches for the treatment of cancer have been proposed: specific inhibitors of serine/threonine and tyrosine kinases, angiogenesis inhibitors, antibodies against receptors/surface molecules on cancer cells, gene therapy approaches and others. In a lot of cases the clinical trials have confirmed the efficacy of these approaches.
Here, we will review the discovered new potential molecular targets for the treatment of human testicular seminomas.
Keywords: Testis, testicular cancer, gonocytes, testicular germ cells, seminomas, tyrosine kinases, angiogenesis inhibitors, antibodies, serine/threonine, molecular targets
Mini-Reviews in Medicinal Chemistry
Title: Potential New Anticancer Molecular Targets for the Treatment of Human Testicular Seminomas
Volume: 11 Issue: 12
Author(s): P. Chieffi
Affiliation:
Keywords: Testis, testicular cancer, gonocytes, testicular germ cells, seminomas, tyrosine kinases, angiogenesis inhibitors, antibodies, serine/threonine, molecular targets
Abstract: In the last years novel therapeutic approaches for the treatment of cancer have been proposed: specific inhibitors of serine/threonine and tyrosine kinases, angiogenesis inhibitors, antibodies against receptors/surface molecules on cancer cells, gene therapy approaches and others. In a lot of cases the clinical trials have confirmed the efficacy of these approaches.
Here, we will review the discovered new potential molecular targets for the treatment of human testicular seminomas.
Export Options
About this article
Cite this article as:
Chieffi P., Potential New Anticancer Molecular Targets for the Treatment of Human Testicular Seminomas, Mini-Reviews in Medicinal Chemistry 2011; 11 (12) . https://dx.doi.org/10.2174/138955711797247770
DOI https://dx.doi.org/10.2174/138955711797247770 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Status and Future Perspective for Research on Medicinal Plants with Anticancerous Activity and Minimum Cytotoxic Value
Current Drug Targets Double Layered Hydroxides as Potential Anti-Cancer Drug Delivery Agents
Mini-Reviews in Medicinal Chemistry Factors Regulating Human Extravillous Trophoblast Invasion: Chemokine-peptidase and CD9-integrin Systems
Current Pharmaceutical Biotechnology The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Management of Gestational Trophoblastic Diseases-An Update
Reviews on Recent Clinical Trials Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?
Current Cancer Drug Targets Progesterone Receptor Agonists and Antagonists as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Current Angiogenesis (Discontinued) Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Gestational Trophoblastic Neoplasia, an Ancient Disease: New Light and Potential Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Gynecomastia in Infants, Children, and Adolescents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
Current Medicinal Chemistry A Storage Protein-Like Trypsin Inhibitor from the Moth Bean (Phaseolus acutifolius) with Antiproliferative Activity Toward Lymphoma Cells
Protein & Peptide Letters Novel Functionalization for Maximizing Cell Turnover from Microcarrier
Current Biotechnology Bestatin as an Experimental Tool in Mammals
Current Drug Metabolism Aminophosphonate Metal Complexes of Biomedical Potential
Current Medicinal Chemistry